Chronic Kidney Disease Trial, Recruiting NCT06613568 Sponsor: Diality Inc. Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT06613568
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 80 years old, whose Care Partner is also at least 18 years old at the time of signing consent
  • People who have been diagnosed with end-stage kidney disease (kidney failure) and are being treated with regular dialysis, with their dialysis working well enough to meet specific targets, and who their kidney specialist considers to be stable
  • People who have a working and stable access point for dialysis (such as a tube in a vein, or a surgically created connection in the arm) that allows blood to flow at a sufficient rate
  • People who, along with their Care Partner, are able to pass a skills and understanding assessment before the end of the training period

Who may not be able to join:

  • People whose haemoglobin (a measure of red blood cells) is too low at the screening stage
  • People who have had repeated episodes of low blood pressure during dialysis sessions that needed medical treatment — such as stopping fluid removal or giving extra fluids — on at least two occasions during the run-in period, including specific patterns of blood pressure that are too low before or during dialysis (confirm with trial site for exact thresholds)
  • People with a documented history of not following their dialysis treatment as prescribed, in a way that would make completing the study unlikely
  • People whose average fluid removal rate during dialysis was too high in the two weeks before screening, based on their medical records
  • People who experienced a serious heart or cardiovascular event in the 90 days before screening

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Cynthia Silva, MD, Diality Inc.

Phone: 949-916-5851

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Diality Inc.
Registry
ClinicalTrials.gov
Start date
6 October 2025
Est. completion
1 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Weekly Standardized Dialysis Adequacy; Adverse Event (AE) Rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov